Tetanus shot may improve glioblastoma treatment
- PMID: 25877510
- DOI: 10.1158/2159-8290.CD-NB2015-053
Tetanus shot may improve glioblastoma treatment
Abstract
Preconditioning the immune system with a tetanus/diphtheria toxoid significantly improved the effectiveness of dendritic cell immunotherapy and extended overall survival in a small, randomized study of patients with glioblastoma.
©2015 American Association for Cancer Research.
Comment on
-
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11. Nature. 2015. PMID: 25762141 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
